The Linked Clinical Trials initiative (LCT) for Parkinson's disease

The Linked Clinical Trials (LCT) initiative is a drug repurposing programme specifically aimed at identifying drugs that can slow the progression of Parkinson's disease (PD). Tom Isaacs was one of the key people behind the idea of LCT in 2011. He ensured it became a priority of The Cure Parkins...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The European journal of neuroscience 2019-02, Vol.49 (3), p.307-315
Hauptverfasser:	Brundin, Patrik, Wyse, Richard K.
Format:	Artikel
Sprache:	eng
Schlagworte:	c-Met protein Clinical trials disease‐modifying trials Drug development Drugs Glucagon Movement disorders Neurodegenerative diseases neuroprotective Parkinson's disease Protein-tyrosine kinase repurposing Therapeutic applications Tom Isaacs
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!